Viewing Study NCT04717635


Ignite Creation Date: 2025-12-24 @ 10:41 PM
Ignite Modification Date: 2025-12-29 @ 11:00 AM
Study NCT ID: NCT04717635
Status: COMPLETED
Last Update Posted: 2025-05-06
First Post: 2020-12-18
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Efficacy and Safety of Canakinumab in Japanese Patients With AOSD
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module